Clinical Endpoint Bioequivalence Studies Are Needed: A Perspective From Brand Drugs
Author:
Affiliation:
1. Merck & Co., Inc. Kenilworth New Jersey USA
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1245
Reference9 articles.
1. Food and Drug Administration.Draft guidance for industry–bioavailability and bioequivalence studies submitted in NDAs or INDs–general considerations. (March 2014). Accessed 21 September 2018.
2. Topical safety and vasoconstrictive assay-based bioequivalence of a new reformulated mometasone cream
3. Food and Drug Administration.Topical dermatologic corticosteroids: in vivo bioequivalence. (June1995). Accessed 23 June 2018.
4. Evaluation of Bioequivalence Between the New Procaterol Hydrochloride Hydrate Dry Powder Inhaler and the Approved Dry Powder Inhaler in Patients With Asthma in a Randomized, Double-Blind, Double-Dummy, Crossover Comparison Study: A Phase 3 Study
5. Food and Drug Administration.Draft guidance on albuterol sulfate. (December2016). Accessed 23 June 2018.
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Pharmacokinetic Bioequivalence and Safety Assessment of Two Venlafaxine Hydrochloride Extended-Release Capsules in Healthy Chinese Subjects Under Fed Conditions: A Randomized, Open-Label, Single-Dose, Crossover Study;Drugs in R&D;2024-06
2. Pharmacokinetics and Pharmacodynamics of Lansoprazole/Sodium Bicarbonate Immediate‐release Capsules in Healthy Chinese Subjects: An Open, Randomized, Controlled, Crossover, Single‐, and Multiple‐dose Trial;Clinical Pharmacology in Drug Development;2023-05-11
3. Pharmacokinetics and Pharmacodynamics of Esomeprazole/Sodium Bicarbonate Immediate-Release Capsules in Healthy Chinese Volunteers: A Cross-Over, Randomized Controlled Trial;Advances in Therapy;2021-02-11
4. Generic Drugs: Expanding Possibilities for Clinical Pharmacology;Clinical Pharmacology & Therapeutics;2019-01-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3